Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06281665 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06281665 · ClinicalTrials.gov record · last posted 2026-06-04

Treatment With Aspirin After Preeclampsia: TAP Trial

Study acronym: TAP
StatusRecruiting
PhasePhase 4
Started2024-05-29
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The objective of this research project is to conduct a single-site pilot trial to assess the feasibility and effect of low-dose aspirin to augment vascular recovery in the immediate postpartum period after preeclampsia through two specific aims: 1) to pilot test the feasibility of conducting a randomized controlled trial of postpartum low dose aspirin vs. placebo, and 2) to assess the effect of postpartum aspirin on endothelial function and blood pressure. Our central hypothesis is that postpartum administration of low-dose aspirin following preeclampsia will be feasible, improve endothelial function, and lower BP at 6 months postpartum. Subjects will undergo 3 study visits involving BP measurements, blood draws, questionnaires, and/or microiontophoresis. Up to 60 adult subjects will be enrolled at Magee-Women's Hospital.

Protocol amendment history 2 changes detected by DataLookout

2026-06-05
notable
Primary completion pushed: 2026-06-01 → 2026-09-01
2026-06-05
minor
Completion pushed: 2027-06-01 → 2027-09-01
Trial Details
NCT Number NCT06281665
Lead Sponsor Malamo Countouris
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension, Eclampsia, Gestational Hypertension, Cardiovascular Diseases, Toxemia, Pregnancy Complications +3 more
Enrollment 60 participants
Start Date 2024-05-29
Primary Completion 2026-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04